GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
11 hedge funds and large institutions have $1.14M invested in Amplify Treatments, Testing and Advancements ETF in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$132K |
2 |
UBS Group
Zurich,
Switzerland
|
+$8.14K |
3 |
IA
IFP Advisors
Tampa,
Florida
|
+$3.72K |
Top Sellers
1 |
GBWM
Granite Bay Wealth Management
Portsmouth,
New Hampshire
|
-$3.63M |
2 |
Goldman Sachs
New York
|
-$203K |
3 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$34.2K |
4 |
Citadel Advisors
Miami,
Florida
|
-$4.03K |
5 |
Morgan Stanley
New York
|
-$88 |